Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 5/20 | 0.84 |
| ▸ | TUBB | P07437 | 5/20 | 0.84 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.84 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.84 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.84 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.84 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.84 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.84 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.84 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.84 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.84 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.84 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 0.84 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 0.84 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.84 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.74 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.74 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.74 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31589366 | 0.91 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL31589078 | 0.91 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Hexamethoxyflavone SCHEMBL30232628 | 0.88 | MEN1 (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Hexamethoxyflavone SCHEMBL987569 | 0.88 | MEN1 (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL21874514 | 0.87 | TUBB4A (0.83) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29750809 | 0.86 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1252875 | 0.86 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL19347141 | 0.85 | ABCG2 (0.72) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Retusin SCHEMBL1421755 | 0.85 | ABCG2 (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Retusin SCHEMBL29496204 | 0.85 | ABCG2 (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118304334-A | Preparation and application of traditional Chinese medicine fructus rhodomyrti liver protection active ingredient | 北京工业大学 | 2024-07-09 | — | — | CN | claimed |
| US-9669003-B2 | Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs | JIN YONGRI (CN) | 2017-06-06 | — | — | US | claimed |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | JIN YONGRI (CN) | 2015-07-16 | — | — | US | claimed |
| US-20140039044-A1 | Hydroxylated Polymethoxyflavone Compositions | WLLGEN, INC. (US) | 2014-02-06 | — | — | US | claimed |
| US-20110123653-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2011-05-26 | — | — | US | claimed |
| JP-2009506057-A | — | — | 2009-02-12 | — | — | JP | claimed |
| EP-2010194-A2 | HYDROXYLATED POLYMETHOXYFLAVONE COMPOSITIONS | Rutgers, The State University of New Jersey (US) | 2009-01-07 | — | — | EP | claimed |
| EP-1928480-A2 | METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION | Wellgen, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| EP-1883300-A2 | COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY | Rutgers, The State University of New Jersey (US) | 2008-02-06 | — | — | EP | claimed |
| US-20070275106-A1 | Hydroxylated polymethoxyflavone compositions | WELLGEN, INC. | 2007-11-29 | — | — | US | claimed |
| WO-2007109071-A2 | HYDROXYLATED POLYMETHOXYFLAVONE COMPOSITIONS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2007-09-27 | — | — | WO | claimed |
| US-20070088078-A1 | Methods for managing adipocyte fat accumulation | WELLGEN, INC. | 2007-04-19 | — | — | US | claimed |
| US-7201928-B1 | Extracts of orange peel for prevention and treatment of cancer | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2007-04-10 | — | — | US | claimed |
| WO-2007024982-A2 | METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION | WELLGEN, INC. (US) | 2007-03-01 | — | — | WO | claimed |
| US-20070042972-A1 | Compositions and methods for optimizing exercise recovery | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2007-02-22 | — | — | US | claimed |
| WO-2006127996-A2 | COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2006-11-30 | — | — | WO | claimed |
| US-10165792-B2 | Hunger minimized juice fasting system | NARASIMHAN SUDARSHAN (US) | 2019-01-01 | — | — | US | disclosed |
| US-9669003-B2 | Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs | JIN YONGRI (CN) | 2017-06-06 | — | — | US | disclosed |
| US-20070042972-A1 | Compositions and methods for optimizing exercise recovery | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2007-02-22 | — | — | US | disclosed |
| WO-2006127996-A2 | COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2006-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042972-A1 | Compositions and methods for optimizing exercise recovery | GYS1, PYGM, PRDX5 | TUBB4A 4627/4885TUBB 4613/4885TUBA3C 4421/4885 |
| US-20070088078-A1 | Methods for managing adipocyte fat accumulation | FABP4, PLIN5, PLIN3 | TUBB4A 2496/4885TUBB 3343/4885TUBA3C 2815/4885 |
| US-20070275106-A1 | Hydroxylated polymethoxyflavone compositions | PLIN5, FANCF, COXFA4 | TUBB4A 4260/4885TUBB 3598/4885TUBA3C 3993/4885 |
| US-20110123653-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY | GYS1, PYGM, PRDX5 | TUBB4A 4627/4885TUBB 4613/4885TUBA3C 4421/4885 |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | CYP2D6, GATAD2A, CYP3A43 | TUBB4A 960/4885TUBB 533/4885TUBA3C 254/4885 |
| US-20140039044-A1 | Hydroxylated Polymethoxyflavone Compositions | PLIN5, FANCF, COXFA4 | TUBB4A 4260/4885TUBB 3598/4885TUBA3C 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.